Incorporation of proteins and enzymes at different stages of the preparation of calcium phosphate coatings on a degradable substrate by a biomimetic methodology

In this work, the possibility of incorporating proteins into calcium phosphate (Ca-P) coatings, prepared on the surface of starch polymeric biomaterials by means of a biomimetic route, was investigated. The morphology, chemical composition and crystallinity of Ca-P coatings was assessed and related to the incorporation of the studied biomolecules. For that, bovine serum albumin (BSA) and aamylase were added in concentrations of 1 mg/ml to simulated body fluid (SBF) solutions, being both added at the nucleation or growth stages of the biomimetic coating process. A biodegradable blend of corn starch/ethylene vinyl alcohol (SEVA-C) was used as substrate and bioactive glass (45S5 BioglassR) was used as the nucleating agent. The obtained Ca-P coatings were characterised by scanning electron microscopy (SEM), energy dispersive spectroscopy (EDS), Fourier transform infrared spectroscopy using an attenuated reflectance device (FTIR-ATR) and thin-film X-ray diffraction (TF-XRD). Additionally, to evaluate the activity of the incorporated enzyme and the stability of the Ca-P films, coated samples were immersed in an SBF solution for different periods of time. The enzyme activity was measured and the morphology of the coating examined by SEM. The results obtained showed that the presence of protein molecules, at the nucleation or growth stages, lead to the formation of a dense Ca-P film presenting different morphologies that were different of the selected coating conditions. FTIR-ATR analysis detected the presence of carbonate and phosphate groups on the Ca-P layer, indicating the formation of a coating similar to the mineral component of vertebrates bone tissue. When proteins were added, amide I and amide II bands, characteristic groups of protein molecules, were also detected, revealing the efficient incorporation of these biomolecules into the Ca-P coatings. Ca-P coatings, with a-amylase incorporated at the nucleation stage, showed no degradation of the film after incubation in SBF for 28 days. The release of increasing concentration of reducing sugars with degradation time revealed that a-amylase was efficiently incorporated in the coating remaining active throughout the coating preparation. This can be a strategy that will allow, in addition of conferring osteoconductive properties to biodegradable polymers, also simultaneously tailoring their degradation kinetics.Fundação para a Ciência e a Tecnologia (FCT

Effects of protein incorporation on calcium phosphate coating

The incorporation of proteins into calcium phosphate (Ca–P) coatings is expected to alter their properties. The aim of this work is, therefore, to study the effect of protein concentration on the formation of Ca–P film. A biodegradable blend of corn starch/ethylene vinyl alcohol (SEVA-C) was used as substrate and bioactive glass (45S5 Bioglass®) was used as a nucleating agent. Bovine serum albumin (BSA) and α-amylase were added, separately, at a concentration of 0.5, 1, and 5 mg/mLto simulated body fluid (SBF) solutions, at the nucleation stage. The incorporation of protein molecules was shown to affect the properties of Ca–P coatings in terms of morphology, composition and crystallinity. Both proteins seem to inhibit in some extent and/or retard the growth of Ca–P nuclei at 0.5 and 5 mg/mL concentrations. FTIR analyses revealed the presence of phosphate and carbonate groups, confiming the formation of a Ca–P layer. The characteristic groups of protein molecules were also detected on the IR spectra, which indicate the efficient incorporation of the proteins into the coatings. When α-amylase was added to the SBF solution the production of reducing sugars was detected, proving the retention of enzyme activity. These results suggest the carrier potential of Ca–P coatings for the sustained delivery of other biologically active proteins and consequently with a strong potential for inducing bone tissue regeneration.This work was partially supported by Portuguese Foundation for Science and Technology (FCT) and was performed within the framework of the project BIOLEARN (POCTI/CTM/38803/2001) through funds from the POCH and/or FEDER Programmes. 1. B. Leonor thanks FCT for providing her a PhD scholarship (SFRH/BD/9031/2002)

Designing biomaterials based on biomineralization of bone

In nature, organisms control crystal nucleation and growth using organic interfaces as templates. Scientists, in the last decades, have tried to learn from nature how to design biomimetic biomaterials inspired by the hierarchical complex structure of bone and other natural mineralised tissues or to control the biomineralization process onto biomaterials substrates to promote the osteoconductive properties of implantable devices. The design of synthetic bone analogues, i.e., with a structure and properties similar to bone, would certainly constitute a major breakthrough in bone tissue engineering. Moreover, many strategies have been proposed in the literature to develop bioactive bone-like materials, for instance using bioactive glasses. Fundamental aspects of biomineralization may be also important in order to propose new methodologies to improve calcification onto the surface of biomaterials or to develop bioactive tridimensional templates that could be used in regenerative medicine. In particular, it has been shown that some chemical groups and proteins, as well as the tridimensional matrix in which calcification would occur, play a fundamental role on the nucleation and growth of hydroxyapatite. All these distinct aspects will be reviewed and discussed in this paper.I. B. Leonor thanks the Portuguese Foundation for Science and Technology (FCT) for providing her a post-doctoral scholarship (SFRH/BPD/26648/2006). This work was supported by the European NoE EXPERTISSUES (NMP3-CT-2004-500283) and by the Portuguese Foundation for Science and Technology, FCT, through the projects PTDC/CTM/68804/2006, PTDC/CTM/67560/2006 and PTDC/FIS/68209/2006

Are coffee silverskin extracts safe for topical use? An in vitro and in vivo approach

Recent changes in regulatory requirements and social views on animal testing have incremented the development of reliable alternative tests for predicting skin and ocular irritation potential of products based on new raw materials. In this regard, botanical ingredients used in cosmetic products are among those materials, and should be carefully reviewed concerning the potential presence of irritant constituents. In particular, cosmetic products used on the face, in vicinity of the eyes or that may come in contact with mucous membranes, should avoid botanical ingredients that contain, or are suspected to contain, such ingredients. In this study, we aimed to evaluate the effect of a new cosmetic ingredient, namely, coffee silverskin (CS), with an in vitro skin and ocular irritation assay using reconstructed human epidermis, EpiSkin™, and human corneal epithelial model, SkinEthics™ HCE, and an in vivo assay. Three different extracts of CS were evaluated. The histology of the models after extracts applications was analysed. The in vitro results demonstrated that extracts were not classified as irritant and the histological analyses proved that extracts did not affect both models structure. The content of caffeine, 5-hydroxymethyl furfural and chlorogenic acid was quantified after the epidermal assay. The in vivo test carried out with the most promising extract (hydroalcoholic) showed that, with respect to irritant effects, these extracts can be regarded as safe for topical application

Distillery residues from Cistus ladanifer (Rockrose) as feedstock for the production of added-value phenolic compounds and hemicellulosic oligosaccharides

ABSTRACT: Cistus ladanifer residues obtained after essential oil distillation were extracted with ethanol and water (CLRext) and subsequently hydrothermally treated (autohydrolysis) in order to selectively hydrolyze hemicelluloses. The extraction removed a significant amount of potentially valuable compounds (40% w/w, dry basis), foremost, phenolic compounds (0.363 and 0.250 g gallic acid equivalent/g extract, respectively, for water and ethanol). Autohydrolysis was studied under diverse severity factors (log R-o), in the temperature range of 150 to 230 degrees C. The hydrolyzates mainly contain oligosaccharides, reaching the highest concentration (23.5g/L) for log R-o of 3.07 (190 degrees C), corresponding to a yield of 15g oligosaccharides/100g dry feedstock. The processed solids are enriched in glucan and lignin. The maximum glucan content (35%) was attained at log R-o of 3.51 (205 degrees C). Py-GC/MS confirmed the reduction of pentose-derived carbohydrates in the solid after hydrothermal treatment and an increase of syringil units in the lignin compared to the untreated biomass. These results show the potential use of this C. ladanifer residue for the production of phenolic extracts, and hemicellulosic oligosaccharides, together with the production of a cellulose- and lignin-rich solid stream.info:eu-repo/semantics/publishedVersio

GO-DACT : a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis

© author(s) (or their employer(s)) 2020. Re-use permitted under CC BY- nC. no commercial re-use. see rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-­NC 4.0) license.Objectives: To assess the efficacy of golimumab in combination with methotrexate (MTX) versus MTX monotherapy in psoriatic arthritis (PsA) dactylitis. Methods: Multicentre, investigator-initiated, randomised, double-blind, placebo-controlled, parallel-design phase 3b trial in 11 Portuguese rheumatology centres. Patients with PsA along with active dactylitis and naive to MTX and biologic disease-modifying antirheumatic drugs (bDMARDs) were randomly assigned to golimumab or placebo, both in combination with MTX. The primary endpoint was Dactylitis Severity Score (DSS) change from baseline to week 24. Key secondary endpoints included DSS and Leeds Dactylitis Index (LDI) response, and changes from baseline in the LDI and MRI dactylitis score. Analysis was by intention-to-treat for the primary endpoint. Results: Twenty-one patients received golimumab plus MTX and 23 MTX monotherapy for 24 weeks. One patient from each arm discontinued. Patient inclusion was halted at 50% planned recruitment due to a favourable interim analysis. Median baseline DSS was 6 in both arms. By week 24, patients treated with golimumab plus MTX exhibited significantly greater improvements in DSS relative to MTX monotherapy (median change of 5 vs 2 points, respectively; p=0.026). In the golimumab plus MTX arm, significantly higher proportions of patients achieved at least 50% or 70% improvement in DSS and 20%, 50% or 70% improvement in LDI in comparison to MTX monotherapy. Conclusions: The combination of golimumab and MTX as first-line bDMARD therapy is superior to MTX monotherapy for the treatment of PsA dactylitis.info:eu-repo/semantics/publishedVersio

Academic success in schools in the Algarve: when leadership is part of the solution and not of the problem

This paper presents the results of a case study conducted among school principals in the southern region of Portugal, located in urban, suburban and rural settings. The five cases that comprise this study were subjected to a final rating of “Very Good” in the external evaluation process of schools, whose data were collected through semi-structured interviews and documentary analysis (regulations and educational project, reports of the external evaluation of responsibility of Inspeção Geral de Educação e Ciência de Portugal). The data collected in this exploratory study were systematized and analyzed according to the following indicators: the students’ academic success, the teachers’ professional development, the organizational development and the identifying features of schools principals. Overall, we cannot affirm the existence of differences according to geographical area, although some particularities which proved to be interesting and indicative of good leadership practices could be highlighted.info:eu-repo/semantics/publishedVersio